The effect of isoflavones on bone mass and bone remodelling markers in postmenopausal women

Turkish Journal of Medical Sciences

Volumn 38, Issue 2, 2008, Pages 145-152

  Öztürk Turhan, Nilgün ^a   Bolkan, Fatma ^a   Iltemir Duvan, Candan ^a   Ardiçoǧlu, Yasemin ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Bone mineral density; Genistein; Isoflavone; Osteocalcin; Serum C terminal telopeptides

Indexed keywords

BIOCHEMICAL ENGINEERING; BIOMARKERS; BLOOD; MINERALS; PATIENT TREATMENT;

BONE MINERAL DENSITY; GENISTEIN; ISOFLAVONE; OSTEOCALCIN; SERUM C-TERMINAL TELOPEPTIDES;

BONE;

ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVIN; ISOFLAVONE DERIVATIVE; OSTEOCALCIN; PLACEBO; STARCH;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE MASS; BONE REMODELING; BONE TURNOVER; BREAST TENDERNESS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LOW DRUG DOSE; LUMBAR SPINE; NORMAL HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STOMACH DISTENSION; TABLET FORMULATION; TREATMENT DURATION; TREATMENT OUTCOME; VAGINA BLEEDING;

EID: 44149120321     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, Offord KP. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986; 77(5): 1487-91.
2. Slemenda C, Hui SL, Longcope C, Johnston CC. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest 1987; 80(5): 1261-9.
3. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332(24): 1589-93.
4. Boroditsky RS. Balancing safety and efficacy focus on endometrial protection. J Reprod Med 2000; 45(3 Suppl): 273-84. Review.
5. Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348(9033): 981-3.
6. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138(3): 863-70.
7. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002; 17(10): 1904-12.
8. Adlercreutz H, Hamalainen E, Gorbach S, Goldin B. Dietary phytooestrogens and the menopause in Japan. Lancet 1992; 339(8803): 1233.
9. Yamaguchi M, Gao YH. Inhibitory effect of genistein on bone resorption in tissue culture. Biochem Pharmacol 1998; 55(1): 71-6.
10. Yamaguchi M, Gao YH. Anabolic effect of genistein and genistin on bone metabolism in the femoral-metaphyseal tissues of elderly rats: the genistein effect is enhanced by zinc. Mol Cell Biochem. 1998; 178(1-2): 377-82.
11. Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 1998; 12(4): 543-57. Review.
12. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996; 126(1): 161-7.
13. Arjmandi BH, Smith BJ. Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 2002; 13(3): 130-7.
14. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68(6 Suppl): 1375S-9S.
15. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88(10): 4740-7.
16. Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004; 292(1): 65-74.
17. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994; 124: 825-32.
18. Sugimoto E, Yamaguchi M. Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem Pharmacol 2000; 59(5): 471-5.
19. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997; 138(10): 4509-12.
20. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138(3): 863-70.
21. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 1996; 61(4): 629-37.
22. Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr 1999; 2(4): 489-504. Review.
23. Watson CS, Pappas TC, Gametchu B. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect 1995; 103 (Suppl 7): 41-50.
24. Gao YH, Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 2000; 5(3): 261-7.
25. Mori M, Sagara M, Ikeda K, Miki T, Yamori Y. Soy isoflavones improve bone metabolism in postmenopausal Japanese women. Clin Exp Pharmacol Physiol 2004; 31 (Suppl 2): S44-6.
26. Camozzi V, Tossi A, Simoni E, Pagani F, Francucci CM, Moro L. Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 2007; 30(6 Suppl): 13-7.
27. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001; 86(11): 5217-21.
28. Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial. Maturitas 2002; 42(4): 295-300.
29. Ettinger B, Genant HK, Steiger P, Madvig P. Low-dosage micronized 17-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992; 166: 479-8.
30. Odell WE, Heath H. Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. Dis Mon 1993; 19: 789-8.
31. Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD. Calcium nutrition and bone health in the elderly. Am J Clin Nutr 1982; 36 (5 Suppl): 986-013.
32. Dempster DW. Bone remodeling. In: Coe FL, Favus MJ, editors. Disorders of Bone and Mineral Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. pp. 315-4.